Elon Musk to meet with German Economy Minister Peter Altmaier

The billionaire is visiting Germany to explore a potential coronavirus vaccine made by CureVac. The biotechnology firm, which Germany has a direct stake in, is in the advanced stages of developing a vaccine candidate.

Billionaire entrepreneur Elon Musk is visiting Germany to scope out the development of a coronavirus vaccine candidate and meet with the economy minister.

Musk is scheduled to meet with Economy Minister Peter Altmaier on Wednesday, according to government sources.

Read more: EU joins WHO's coronavirus vaccine alliance, offers €400 million investment

On Tuesday, the Tesla CEO visited biotechnology company CureVac in the southwestern town of Tübingen. The firm is in the advanced stages of developing a potential vaccine for the virus.

On Sunday, Musk announced that he would head to Germany to discuss cooperation with CureVac and the construction of a Tesla factory in Grünheide, on the outskirts of Berlin.

Read more: Global race to buy coronavirus vaccine: What you need to know

"Tesla, as a side project, is building RNA microfactories for CureVac and possibly others," he tweeted in July.

The car manufacturer has not yet released details on the project.

Starting in mid-2021, Tesla plans to produce around 500,000 electric vehicles annually at the Grünheide "Gigafactory," creating around 12,000 jobs. The plan does not yet have full environmental approval.

The European Commission said in August that it was in advanced talks with CureVac, which is partly owned by the German government, regarding the purchase of 225 million doses of its vaccine. In June, Germany paid €300 million ($356 million) for a 23% stake in the company.

Until then, billionaire German entrepreneur Dietmar Hopp, co-founder of German software company SAP, had been the biotech firm's biggest investor.

Germany also signed an agreement with France, Italy and the Netherlands to procure 300 million doses of a potential coronavirus vaccine from the British-Swedish pharmaceutical group AstraZeneca. Under the deal, all EU member states must receive supplies of the vaccine as soon as it is discovered.

Read more: Coronavirus: German vaccine study draws thousands of volunteers

Date 02.09.2020
Related Subjects Coronavirus
Keywords Elon Musk, Altmaier, vaccine, coronavirus, COVID-19

Permalink https://p.dw.com/p/3htsx